DK0861085T3 - Antivirale isolater opnået fra igler - Google Patents
Antivirale isolater opnået fra iglerInfo
- Publication number
- DK0861085T3 DK0861085T3 DK96937576T DK96937576T DK0861085T3 DK 0861085 T3 DK0861085 T3 DK 0861085T3 DK 96937576 T DK96937576 T DK 96937576T DK 96937576 T DK96937576 T DK 96937576T DK 0861085 T3 DK0861085 T3 DK 0861085T3
- Authority
- DK
- Denmark
- Prior art keywords
- hiv
- mum
- substances
- leeches
- isolates
- Prior art date
Links
- 241000545744 Hirudinea Species 0.000 title abstract 4
- 230000000840 anti-viral effect Effects 0.000 title 1
- 239000000126 substance Substances 0.000 abstract 4
- 230000000120 cytopathologic effect Effects 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 230000017960 syncytium formation Effects 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 238000002965 ELISA Methods 0.000 abstract 1
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 206010038997 Retroviral infections Diseases 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000010790 dilution Methods 0.000 abstract 1
- 239000012895 dilution Substances 0.000 abstract 1
- 239000000284 extract Substances 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 210000001616 monocyte Anatomy 0.000 abstract 1
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 238000000638 solvent extraction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP95203099 | 1995-11-13 | ||
| PCT/NL1996/000444 WO1997017981A1 (en) | 1995-11-13 | 1996-11-13 | Anti-viral isolates obtainable from leeches |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0861085T3 true DK0861085T3 (da) | 2005-11-21 |
Family
ID=8220829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96937576T DK0861085T3 (da) | 1995-11-13 | 1996-11-13 | Antivirale isolater opnået fra igler |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6270808B1 (da) |
| EP (1) | EP0861085B1 (da) |
| JP (1) | JP2000500156A (da) |
| AT (1) | ATE299707T1 (da) |
| AU (1) | AU7508196A (da) |
| CA (1) | CA2235394A1 (da) |
| DE (1) | DE69634959T2 (da) |
| DK (1) | DK0861085T3 (da) |
| ES (1) | ES2246498T3 (da) |
| WO (1) | WO1997017981A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101095697A (zh) * | 2006-06-28 | 2008-01-02 | 李振国 | 水蛭和/或地龙分子量5800道尔顿以下的提取物 |
| EP2316465A1 (en) * | 2009-10-15 | 2011-05-04 | Centre National De La Recherche Scientifique | Use of extract of leeches' saliva as anti-bacterial agent for the manufacture of different compositons |
| US8784896B2 (en) | 2012-09-17 | 2014-07-22 | Biopep Solutions, Inc | Antioxidant therapy with a whole, leech saliva extract |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL86857A (en) * | 1988-06-24 | 1994-04-12 | Yissum Res Dev Co | Platelet-aggregating inhibitory agents from leech saliva and pharmaceutical preparations containing the same |
| GB8927913D0 (en) | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Amino acid derivatives |
| ATE164839T1 (de) | 1990-11-19 | 1998-04-15 | Monsanto Co | Retrovirale proteaseinhibitoren |
| ES2112880T3 (es) | 1991-11-08 | 1998-04-16 | Merck & Co Inc | Inhibidores de la proteasa de vih utiles para el tratamiento del sida. |
| JP3517238B2 (ja) | 1992-09-09 | 2004-04-12 | アムジェン インコーポレイテッド | レトロウイルス感染の阻害 |
| ATE211462T1 (de) | 1992-10-30 | 2002-01-15 | Searle & Co | N-substituierte hydroxyethylaminosulfamidsäure- derivate verwendbar als inhibitoren retroviraler proteasen |
| TW492975B (en) * | 1993-07-26 | 2002-07-01 | Novartis Ag | Tryptase inhibitor |
| HUT75225A (en) | 1993-11-19 | 1997-04-28 | Parke Davis & Co | 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents |
| ES2174921T3 (es) | 1993-12-15 | 2002-11-16 | Merck & Co Inc | Inhibidores de la proteasa del vih. |
| IL111991A (en) | 1994-01-28 | 2000-07-26 | Abbott Lab | Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent |
| DE4412174A1 (de) * | 1994-04-08 | 1995-10-19 | Schramm Wolfgang Prof Dr | Peptide, Verfahren zu ihrer Herstellung und ihre Verwendung |
| WO1996013585A1 (en) * | 1994-10-28 | 1996-05-09 | Clodica S.A. | A novel family of protease inhibitors, and other biologic active substances |
-
1996
- 1996-11-13 US US09/068,417 patent/US6270808B1/en not_active Expired - Fee Related
- 1996-11-13 WO PCT/NL1996/000444 patent/WO1997017981A1/en active IP Right Grant
- 1996-11-13 EP EP96937576A patent/EP0861085B1/en not_active Expired - Lifetime
- 1996-11-13 ES ES96937576T patent/ES2246498T3/es not_active Expired - Lifetime
- 1996-11-13 DE DE69634959T patent/DE69634959T2/de not_active Expired - Fee Related
- 1996-11-13 JP JP9518757A patent/JP2000500156A/ja not_active Ceased
- 1996-11-13 CA CA002235394A patent/CA2235394A1/en not_active Abandoned
- 1996-11-13 AU AU75081/96A patent/AU7508196A/en not_active Abandoned
- 1996-11-13 DK DK96937576T patent/DK0861085T3/da active
- 1996-11-13 AT AT96937576T patent/ATE299707T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69634959T2 (de) | 2006-05-24 |
| CA2235394A1 (en) | 1997-05-22 |
| EP0861085B1 (en) | 2005-07-20 |
| DE69634959D1 (de) | 2005-08-25 |
| EP0861085A1 (en) | 1998-09-02 |
| JP2000500156A (ja) | 2000-01-11 |
| ES2246498T3 (es) | 2006-02-16 |
| ATE299707T1 (de) | 2005-08-15 |
| WO1997017981A1 (en) | 1997-05-22 |
| US6270808B1 (en) | 2001-08-07 |
| AU7508196A (en) | 1997-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2208420A1 (en) | Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission | |
| PooLPOL et al. | Enhancement of cucumber mosaic virus multiplication by zucchini yellow mosaic virus in doubly infected cucumber plants | |
| DE60036403D1 (de) | Verfahren zur herstellung von gereinigtem hcv rna durch isolierung von exosomen | |
| AR063315A2 (es) | Composicion que comprende un virus, y metodos para concentrar y purificar preparados de virus | |
| NO20075810L (no) | Aminosyrehydroksyetylaminosulfonamid retrovirale proteaseinhibitorer | |
| NO983435L (no) | Aspartylproteaseinhibitorer | |
| DK0787191T4 (da) | Nukleotidsekvenser af HIV-1 type (eller undertype) O retrovirusantigener | |
| Baboonian et al. | HIV-1 proteinase is required for synthesis of pro-viral DNA | |
| DK0730462T3 (da) | Kondensationspolymer af en aromatisk sulfonsyre og et aldehyd til inhibition af HIV-infektivitet | |
| BR9912142A (pt) | 6-benzil-4-oxipirimidinas substituìdas, processopara sua preparação e composições contendo-as | |
| DK0861085T3 (da) | Antivirale isolater opnået fra igler | |
| DK1159968T3 (da) | Attenuerede stammer af Dengue-virus og deres anvendelse i en vaccinesammensætning | |
| YOSHIDA et al. | Attenuated isolates of cucumber mosaic virus produced by satellite RNA and cross protection between attenuated isolates and virulent ones | |
| Apandi et al. | Identification of Chikungunya virus strains circulating in Kelantan, Malaysia in 2009 | |
| Nicoletti et al. | Antiviral properties of a crude extract from a green alga Caulerpa taxifolia (Vahl) C. Agardh | |
| DE69232417D1 (de) | Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren | |
| DE69110891T2 (de) | Peptide und analoge und mischungen davon zum nachweis der gegen die viren htlv-1 und htlv-ii gerichteten antikörper. | |
| DE68909019D1 (de) | Virushemmende Zusammensetzung und ihre Anwendungen. | |
| WO2006109174A3 (en) | Hiv vaccine comprising a glycoprotein 120 signal sequence with no more than one positively charged amino acid | |
| FR2840318B1 (fr) | Nouveaux sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih | |
| DE60227665D1 (de) | Tsg101 als inhibitor der hiv-produktion | |
| EP0469348A3 (en) | Cdna sequence and detection of hepatits c virus | |
| DE4039925A1 (de) | Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung | |
| PEDERSEN JR et al. | Comparative analyses of members of the Venezuelan equine encephalomyelitis virus complex | |
| DE68913932T2 (de) | Arzneimittel für die Behandlung oder die Verhütung von Infektionen mit HIV durch Immunisierung, und Verfahren zur Herstellung. |